Sign inJoin waitlistJoin the waitlist

Ugwuji Maduekwe

Associate Dean, Associate Professor · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · · · · · · · ·

History

Associate Professor · Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Medical College of Wisconsin Affiliated Hospitals, Inc
Present
Medical College of Wisconsin Affiliated Hospitals, Inc
Present

Complex General Surgical Oncology
UPMC
2011–2013
General Surgery
Massachusetts General Hospital
2004–2011
Center
2004–2007
Harvard Medical School
Harvard Medical School
2000–2004
The University of Texas at Dallas
1996–2000

Research

Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database
Annals of Surgery · 2012 · 172 citations
Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer
Annals of Surgery · 2019 · 136 citations
Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women
Cancer · 2020 · 98 citations

Sam Yoon
8 papers
Anai Kothari
6 papers · 1 as a fellow
Daniel Abbott
5 papers
Fabian Johnston
5 papers
Sameer Patel
5 papers
Shishir Maithel
5 papers
Callisia Clarke
4 papers
DR
David Rattner
4 papers
Greg Wilson
4 papers
GL
Gregory Lauwers
4 papers
Hong Kim
4 papers · 1 as a resident
Jordan Cloyd
4 papers

Clinical trials

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Site PI · Recruiting · Phase 2, Phase 3
ECOG-ACRIN Cancer Research Group
2025–2030
Promoting CT Engagement for Pancreatic Cancer With App
Site PI · Recruiting
UNC Lineberger Comprehensive Cancer Center
2024–2027
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Sub-investigator · Recruiting · Phase 2
UNC Lineberger Comprehensive Cancer Center
2019–2030